List of Excipients in API cefditoren pivoxil
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing cefditoren pivoxil
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Vansen Pharma Inc | SPECTRACEF | cefditoren pivoxil | 44004-801 | CARNAUBA WAX | |
| Vansen Pharma Inc | SPECTRACEF | cefditoren pivoxil | 44004-801 | CROSCARMELLOSE SODIUM | |
| Vansen Pharma Inc | SPECTRACEF | cefditoren pivoxil | 44004-801 | D&C RED NO. 27 | |
| Vansen Pharma Inc | SPECTRACEF | cefditoren pivoxil | 44004-801 | FD&C BLUE NO. 1 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for cefditoren pivoxil
Excipient focus: CARNAUBA WAX
cefditoren pivoxil drug variants containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Vansen Pharma Inc | cefditoren pivoxil | 44004-801 |
| Pharma RomLev Inc | cefditoren pivoxil | 44009-801 |
| >Company | >Ingredient | >NDC |
cefditoren pivoxil drug variants not containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
cefditoren pivoxil drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Vansen Pharma Inc | cefditoren pivoxil | 44004-801 |
| Pharma RomLev Inc | cefditoren pivoxil | 44009-801 |
| >Company | >Ingredient | >NDC |
cefditoren pivoxil drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 27
cefditoren pivoxil drug variants containing D&C RED NO. 27
| Company | Ingredient | NDC |
|---|---|---|
| Vansen Pharma Inc | cefditoren pivoxil | 44004-801 |
| Pharma RomLev Inc | cefditoren pivoxil | 44009-801 |
| >Company | >Ingredient | >NDC |
cefditoren pivoxil drug variants not containing D&C RED NO. 27
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
cefditoren pivoxil drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Vansen Pharma Inc | cefditoren pivoxil | 44004-801 |
| Pharma RomLev Inc | cefditoren pivoxil | 44009-801 |
| >Company | >Ingredient | >NDC |
cefditoren pivoxil drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
cefditoren pivoxil drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Vansen Pharma Inc | cefditoren pivoxil | 44004-801 |
| Pharma RomLev Inc | cefditoren pivoxil | 44009-801 |
| >Company | >Ingredient | >NDC |
cefditoren pivoxil drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
cefditoren pivoxil drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Vansen Pharma Inc | cefditoren pivoxil | 44004-801 |
| Pharma RomLev Inc | cefditoren pivoxil | 44009-801 |
| >Company | >Ingredient | >NDC |
cefditoren pivoxil drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
cefditoren pivoxil drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Vansen Pharma Inc | cefditoren pivoxil | 44004-801 |
| Pharma RomLev Inc | cefditoren pivoxil | 44009-801 |
| >Company | >Ingredient | >NDC |
cefditoren pivoxil drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
cefditoren pivoxil drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Vansen Pharma Inc | cefditoren pivoxil | 44004-801 |
| Pharma RomLev Inc | cefditoren pivoxil | 44009-801 |
| >Company | >Ingredient | >NDC |
cefditoren pivoxil drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOLS
cefditoren pivoxil drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Vansen Pharma Inc | cefditoren pivoxil | 44004-801 |
| Pharma RomLev Inc | cefditoren pivoxil | 44009-801 |
| >Company | >Ingredient | >NDC |
cefditoren pivoxil drug variants not containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
cefditoren pivoxil drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Vansen Pharma Inc | cefditoren pivoxil | 44004-801 |
| Pharma RomLev Inc | cefditoren pivoxil | 44009-801 |
| >Company | >Ingredient | >NDC |
cefditoren pivoxil drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
cefditoren pivoxil drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Vansen Pharma Inc | cefditoren pivoxil | 44004-801 |
| Pharma RomLev Inc | cefditoren pivoxil | 44009-801 |
| >Company | >Ingredient | >NDC |
cefditoren pivoxil drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CASEINATE
cefditoren pivoxil drug variants containing SODIUM CASEINATE
| Company | Ingredient | NDC |
|---|---|---|
| Vansen Pharma Inc | cefditoren pivoxil | 44004-801 |
| Pharma RomLev Inc | cefditoren pivoxil | 44009-801 |
| >Company | >Ingredient | >NDC |
cefditoren pivoxil drug variants not containing SODIUM CASEINATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM TRIPOLYPHOSPHATE
cefditoren pivoxil drug variants containing SODIUM TRIPOLYPHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Vansen Pharma Inc | cefditoren pivoxil | 44004-801 |
| Pharma RomLev Inc | cefditoren pivoxil | 44009-801 |
| >Company | >Ingredient | >NDC |
cefditoren pivoxil drug variants not containing SODIUM TRIPOLYPHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
cefditoren pivoxil drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Vansen Pharma Inc | cefditoren pivoxil | 44004-801 |
| Pharma RomLev Inc | cefditoren pivoxil | 44009-801 |
| >Company | >Ingredient | >NDC |
cefditoren pivoxil drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch